About Carisma Therapeutics, Inc. - Common Stock (CARM)
Carisma Therapeutics, Inc. is a biotechnology company focused on the development of innovative cell therapies for the treatment of cancer and other diseases. The company specializes in harnessing the power of engineered immune cells, particularly macrophages, to target and destroy tumor cells more effectively. By utilizing advanced genetic engineering techniques, Carisma aims to enhance the body's immune response against cancer, striving to improve patient outcomes and provide novel treatment options for patients with various malignancies. Through research and clinical development, Carisma is dedicated to advancing its therapies toward commercialization and transforming cancer care. Read More
Stay up-to-date with the latest market trends one hour before the close of the markets on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session.
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.
Carisma Therapeutics Inc. (NASDAQ: CARM) shares are trading higher on Friday following the company's announcement of a significant development in its collaboration with Moderna.
Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Technologies launched ElecAlytics, an AI-Powered analytics suite added to its ElecTech platform for political campaigns.
